Impact of Treatment with Direct Acting Antiviral Drugs on Glycemic Control in Patients with Hepatitis C and Diabetes Mellitus

Impact of Treatment with Direct Acting Antiviral Drugs on Glycemic Control in Patients with Hepatitis C and Diabetes Mellitus

Aim. To assess the effect of treating chronic hepatitis C virus (HCV) infection with direct acting antiviral drugs (DAAs) on glycemic control in patients with concomitant diabetes mellitus (DM). Methods. We performed a retrospective case-control study in a viral hepatitis ambulatory clinic in Shreve...

Full description

Bibliographic Details
Main Authors:	Pradeep Kumar Mada, Matthew E. Malus, Arvin Parvathaneni, Bing Chen, Gabriel Castano, Sharon Adley, Maureen Moore, Michinari Hieda, Mohammed J. Alam, Mark Feldman, John William King
Format:	Article
Language:	English
Published:	Hindawi Limited 2020-01-01
Series:	International Journal of Hepatology
Online Access:	http://dx.doi.org/10.1155/2020/6438753

Similar Items

Effect of Treatment with Direct Acting Antiviral on Glycemic Control in Patients with Diabetes Mellitus and Chronic Hepatitis C
by: Jonathan G. Stine, et al.
Published: (2017-03-01)

Risk assessment and management of hepatitis B reactivation from direct-acting antivirals for hepatitis C
by: Maureen Whitsett, et al.
Published: (2019-06-01)

Eradication of hepatitis C virus with direct‐acting antivirals improves glycemic control in diabetes: A multicenter study
by: Hirokazu Takahashi, et al.
Published: (2021-02-01)

Factors Associated with Improved Glycemic Control by Direct-Acting Antiviral Agent Treatment in Egyptian Type 2 Diabetes Mellitus Patients with Chronic Hepatitis C Genotype 4
by: Alaaeldin Abdelsalam Dawood, et al.
Published: (2017-08-01)

Glycemic control after initiating direct-acting antiviral agents in patients with hepatitis C virus and type 2 diabetes mellitus using the united states integrated healthcare system
by: Alicia Halim Wong, et al.
Published: (2020-01-01)

Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control
by: Mohamed Mohei El Badry, et al.
Published: (2020-11-01)

Markedly Improved Glycemic Control in Poorly Controlled Type 2 Diabetes following Direct Acting Antiviral Treatment of Genotype 1 Hepatitis C
by: Raymond Anthony Pashun, et al.
Published: (2016-01-01)

Understanding the Importance of Glycemic Index and Glycemic Load in the Management of Diabetes Mellitus
by: G. K. Pal
Published: (2011-04-01)

New treatment of hepatitis C (Direct Acting Antiviral)
by: Mohsen Akhondi-Meybodi
Published: (2019-10-01)

Direct Acting Antivirals for the Treatment of Chronic Viral Hepatitis
by: Peter Karayiannis
Published: (2012-01-01)

Effect of new direct-acting antiviral drugs on insulin resistance and glycemic control after treatment of chronic hepatitis C virus infection in type 2 diabetic patients
by: Alaa E.M Hashim, et al.
Published: (2017-01-01)

Glycemic control in patients with diabetes mellitus on hemodialysis
by: K G Lobanova, et al.
Published: (2019-10-01)

Glycemic Variability and Type 2 Diabetes Mellitus
by: Nicolae HÂNCU, et al.
Published: (2013-02-01)

The Importance of the Management of Infectious Complications for Patients with Left Ventricular Assist Device
by: Michinari Hieda, et al.
Published: (2015-08-01)

Mechanisms of Hepatitis C Viral Resistance to Direct Acting Antivirals
by: Asma Ahmed, et al.
Published: (2015-12-01)

Mexican experience with direct-acting antivirals in the treatment of hepatitis C
by: J.L. Pérez Hernández, et al.
Published: (2020-09-01)

Can biopolymers act as antiviral agents?
by: J. Seppala, et al.
Published: (2020-11-01)

Pulmonary function tests in type 2 diabetes mellitus and their association with glycemic control and duration of the disease
by: Swati H Shah, et al.
Published: (2013-01-01)

Oscillatory pattern of glycemic control in patients with diabetes mellitus
by: Manuel Vasquez-Muñoz, et al.
Published: (2021-03-01)

Refractory Hepatic Hydrothorax in Chronic Hepatitis C Controlled by Direct-acting Antivirals
by: Myung Hee Kim, et al.
Published: (2020-02-01)

Direct-Acting Antiviral Drugs and Occurrence of Hepatocellular Carcinoma: Unjust or Oppressed
by: Hassany SM, et al.
Published: (2020-06-01)

Bioequivalent pharmacokinetics for generic and originator hepatitis C direct-acting antivirals
by: Andrew Hill, et al.
Published: (2018-04-01)

Hepatitis C virus, directly acting antivirals and Guillain-Barré syndrome
by: Manish Balwani, et al.
Published: (2018-01-01)

Incidence of depression in patients with hepatitis C treated with direct-acting antivirals
by: Elfi Egmond, et al.

Direct Acting Antivirals in Patients with Chronic Hepatitis C and Down Syndrome
by: Eric R. Yoo, et al.
Published: (2016-01-01)

Discovery and evaluation of direct acting antivirals against hepatitis C virus
by: Abdurakhmanov, Eldar
Published: (2015)

Effects of Age on Treatment of Chronic Hepatitis C with Direct Acting Antivirals
by: Alexandre Pariente, et al.
Published: (2019-01-01)

The Direct-Acting Antivirals for Hepatitis C Virus and the Risk for Hepatocellular Carcinoma
by: Paulina Chinchilla-López, et al.
Published: (2017-05-01)

The efficacy of direct-acting antiviral therapy in patients with chronic hepatitis C
by: Irina RUSU, et al.
Published: (2020-03-01)

The effect of type 2 diabetes mellitus and glycemic level on physical performance tests in older adults
by: Bing Hong Ji, et al.
Published: (2012)

Development of a long-acting direct-acting antiviral system for hepatitis C virus treatment in swine
by: Verma, Malvika, et al.
Published: (2020)

A viral dynamic model for treatment regimens with direct-acting antivirals for chronic hepatitis C infection.
by: Bambang S Adiwijaya, et al.
Published: (2012-01-01)

Influenza in today: direct-acting antiviral therapy
by: T. V. Sologub
Published: (2015-12-01)

GLYCEMIC AND NON-GLYCEMIC EFFECTS OF EXENATIDE IN PATIENTS WITH DIABETES MELLITUS OF TYPE 2 (DM2) WITH MYOCARDIAL INFARCTION
by: A. Yu. BABENKO, et al.
Published: (2016-12-01)

Low-Glycemic-Index/Load Desserts Decrease Glycemic and Insulinemic Response in Patients with Type 2 Diabetes Mellitus
by: Vasiliki Argiana, et al.
Published: (2020-07-01)

Retrospective Descriptive Analysis of West Nile Neuroinvasive Disease (WNND) in Northwest Louisiana
by: Pradeep Kumar Mada, et al.
Published: (2020-01-01)

Nanocarriers for Oral Delivery of Biomacromolecules for Glycemic Control in Diabetes Mellitus
by: Lin, Po-Yen, et al.
Published: (2018)

Vitamin D and glycemic control in diabetes mellitus type 2
by: Ifigenia Kostoglou-Athanassiou, et al.
Published: (2013-08-01)

Depression in patients with diabetes mellitus and its relationship with the glycemic control
by: Andrés Vázquez Machado, et al.
Published: (2020-10-01)

Glycemic control and periodontal disease in type 2 diabetes mellitus patients: A cross-sectional study
by: Vaibhav Tandon, et al.
Published: (2015-01-01)